Related Experiment Video
Updated: Aug 14, 2025
Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
Published on: September 20, 2018
Drugging the epigenome in the age of precision medicine
Taylor Feehley1, Charles W O'Donnell1, John Mendlein2
1Omega Therapeutics, 20 Acorn Park Drive, Suite 400, Cambridge, MA, 02140, USA.
Background:
Modulating the epigenome has long been considered a potential opportunity for therapeutic intervention in numerous disease areas with several approved therapies marketed, primarily for cancer. Despite the overall promise of early approaches, however, these drugs have been plagued by poor pharmacokinetic and safety/tolerability profiles due in large part to off-target effects and a lack of specificity.
Results:
Recently, there has been marked progress in the field on a new generation of epigenomic therapies which address these challenges directly by targeting defined loci with highly precise, durable, and tunable approaches. Here, we review the promise and pitfalls of epigenetic drug development to date and provide an outlook on recent advances and their promise for future therapeutic applications.
Conclusions:
Novel therapeutic modalities leveraging epigenetics and epigenomics with increased precision are well positioned to advance the field and treat patients across disease areas in the coming years.
Insights
New epigenomic therapies offer precise, durable treatments for diseases. These advanced approaches overcome limitations of earlier epigenetic drugs, improving patient outcomes.
Area of Science:
- Epigenetics and Epigenomics
- Therapeutic Drug Development
Background:
- Epigenome modulation is a therapeutic strategy for various diseases, particularly cancer.
- Early epigenetic drugs faced challenges with pharmacokinetics, safety, and specificity, leading to off-target effects.
Purpose of the Study:
- To review the progress, challenges, and future outlook of epigenetic drug development.
- To highlight recent advances in precision epigenomic therapies.
Main Methods:
- Review of current literature on epigenetic drug development.
- Analysis of novel therapeutic modalities targeting specific epigenetic loci.
Main Results:
- A new generation of epigenomic therapies demonstrates improved precision, durability, and tunability.
- These advanced therapies address the limitations of earlier epigenetic drugs.
Conclusions:
- Novel epigenomic therapies with enhanced precision are poised to significantly advance patient treatment across diverse disease areas.
- The field is moving towards more effective and safer epigenetic interventions.
Related Concept Videos
01:46Epigenetic Regulation
02:30Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
01:59CRISPR
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
00:49What is Genetic Engineering?